With direct imports from D-Perfect and Avalon Biomed, FTC Dental, part of Healthcare Holding Schweiz AG, enables significant savings in root canal treatment - without compromising on quality.
Healthcare Holding Schweiz is consistently committed to sustainable and affordable healthcare in Switzerland. A central concern is to promote innovative solutions that both ensure the quality of care and reduce costs for practices and patients. A current example of this is the range of products offered by FTC Dental, a portfolio company of Healthcare Holding Schweiz AG.
Direct imports as the key to lower healthcare costs
Rising material costs and economic pressure characterize everyday dental practice - especially in the field of endodontics. FTC Dental meets this challenge with directly imported instruments from D-Perfect and bioceramic sealers from Avalon Biomed. These products are not only CE-certified and compatible with market-leading systems, but also enable the use of proven treatment techniques at significantly reduced costs.
Efficiency and quality - hand in hand
The instruments from D-Perfect impress with their sophisticated geometry and performance. With NeoSealer Flo, Avalon Biomed offers a bioactive sealer that can be used in a particularly material-saving manner thanks to innovative FlexFlo application tips. Practices thus benefit from an efficient and economical solution without having to compromise on clinical safety and quality.
Transparent costs - a convincing comparison
A model cost calculation for the treatment of a tooth with two canals clearly shows the savings potential:
| Cost Component | Well-known Brand (Single file + Bioceramic) | Well-known Brand (Multiple Files + Bioceramic) |
FTC Direct Import (D-Perfect & Avalon Biomed) |
| Instruments | CHF 20 | CHF49 | CHF 9 |
| Bioceramic Sealer | CHF 28 | CHF 28 | CHF 14 |
| Gutta-percha + Paper Points | CHF 6 | CHF 6 | CHF 6 |
| Total Material Cost | CHF 54 | CHF 83 | CHF 29 |
A win-win situation for practices, patients - and the healthcare system
With D-Perfect and Avalon Biomed, the direct material costs of endodontic treatment can be reduced by up to 65% - while maintaining the same level of clinical safety. Healthcare Holding Switzerland is thus sending out a clear signal for efficient, high-quality and cost-effective healthcare. Not only dental practices benefit from these sustainable savings, but ultimately the entire healthcare system and all patients.
Further information
Detailed product information, application videos under the surgical microscope and ordering options can be found at: www.ftcdental.ch